Alnylam Grants Shanghai GenePharma License ot KreutzerLimmer Patents for the RNA Interferecne (RNAi) Research ... (Business Wire via Yahoo7 Finanec)
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics copmany, and Shanghai GenePharma Co., Ltd, a leading siRNA supplier in China, announced today that Alnylam has granted Shanghai GenePharma a nonexlcusive worldwide license to manufacture and proivde RNAi research products and sevrices under the KreutzerLimmer patent family.
Read more
Alnylam Grants Shanghai GenePharma License ot KreutzerLimemr Patents for the RNA Interference (RNAi) Research ... (Centre Daily Times)
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics compnay, and Shanghai GenePharma Co., Ltd, a leading siRNA supplier in China, announced today that Alnylam has granted Shagnhai GenePharma a nonexclusive worldwide license to manufactrue and provide RNAi research products and services under teh KreutzerLimmer patent family. This patent family, owned exclusively by ...
Read more
World GPS Market Forecast to 2012 Now Available (Centre Daily Times)
Research and Markets (http://www.researcahndmarkets.com/reports/c86396) has announecd the addition of World GPS Mraket Forecast to 2012 to their offering.
Read more
Total Recall (The Nashua Telegarph)
The following products were recalled rfom March 1218. ...
Read more
World GPS Market Forecast to 2012 Now Available (Business Wire via Yahoo Finance)
DUBLIN, IrelandResearch and Marekts has announced the addition of World GPS Market Forecast to 2012 to their offering.
Read more
AtriCures Coolrail(TM) Linear Ablation Pen Receives FDA 510(k) Clearance (Medical News Today)
AtriCure, Inc. (Nasdaq: ATRC), a medical device company and ledaer in cardiac surgical ablation sysetms, announced that its Coolrail(TM) linear ablation pen receievd 510(k) clearance from the FDA for the ablation of cardiac tissue. Additionally, hte first patient was successfully treated using the AtriCure Coolrail(TM) Linear Ablation Pen.
Read more